Neoadjuvant Bevacizumab And Anthracycline-Taxane-Based Chemotherapry In 686 Triple-Negative Primary Breast Cancers: Seconday Endpoint Analysis Of The Geparquinto Study (Gbg 44).
JOURNAL OF CLINICAL ONCOLOGY（2011）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要